Future Biosimilars: Upcoming Patent Expirations and Market Entry
Explore the upcoming wave of biosimilars as major patents for drugs like Keytruda and Eylea expire. Learn about the differences from generics, market entry timelines, pricing impacts, and what this means for patient care.